Clinical experience and future directions for low-density lipoprotein apheresis in the United States

Therapeutic Apheresis

Volumn 1, Issue 3, 1997, Pages 249-252

  Gordon, Bruce R ^a,b   Saal, Stuart D ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b ROGOSIN INSTITUTE   (United States)

Author keywords

Coronary artery disease; Dextran sulfate cellulose columns; Low density lipoprotein apheresis

Indexed keywords

LOW DENSITY LIPOPROTEIN;

APHERESIS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; INSTRUMENTATION; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BLOOD COMPONENT REMOVAL; CORONARY DISEASE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; RANDOMIZED CONTROLLED TRIALS;

EID: 0031195720     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00146.x     Document Type: Article

References (21)

1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
3. Schuff-Werner P, Armstrong VW, Eisenhauer TH, Thiery J, Seidel D. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP). Contrib Infusion Ther 1988;23:118-26.
4. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 1981;2:1005-7.
5. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-22.
6. Gordon BR, Kelsey SF, Bilheimer DW, Brown DC, Dau PC, Gotto AM Jr, Illingworth H, Leitman SF, Prihoda JS, Stein EA, Stern TN, Zavoral JH, Zwiener RJ. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol 1992;70:1010-6.
7. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987;68:19-25.
8. Schuff-Werner P, Gohlke H, Bartmann U, Corti MC, Dinsenbacher A, Eisenhauer T, Grutzmacher P, Keller C, Kettner U, Kleophas W, Koster W, Olbricht CJ, Richter WO, Seidel D and the HELP-Study Group. The HELP-LDL Apheresis Multicenter Study, an angiographically assessed trial on the role of LDL apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 1994;24: 724-32.
9. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A, Goto Y. Regression of coronary atherosclerosis by combined LDL apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study. Atherosclerosis 1992;95:1-13.
10. Borberg H, Oette K. Experience with and conclusions from three different trials on low density lipoprotein apheresis. In: Agishi T, Kawamura A, Mineshima M, eds. Therapeutic plasmapheresis (XII). New Utricht: VSP, 1993:13-20.
11. Thompson GR, Maher VM, Mathews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, de Feyter P, Henderson P. The familial hypercholesterolaemia regression study: A randomised trial of low-density-lipoprotein apheresis. Lancet 1995;345:811-6.
12. Kroon AA, Aengevaeren WR, van der Werf T, Uijen GJ, Reiber JH, Bruschke AV, Stalenhoef AF. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93:1826-35.
13. Kroon AA, van Asten WN, Stalenhoef AF. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Ann Intern Med 1996;125:945-54.
14. Uno H, Ueki Y, Murashima J, Miyake S, Tominaga Y, Eguchi K, Yano K. Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerosis obliterans. Atherosclerosis 1995;116: 93-102.
15. Sato Y, Agishi T. Low-density lipoprotein adsorption for arteriosclerotic patients. Artif Organs 1996;20:324-7.
16. Daida H, Young JL, Yokoi H, Kanoh T, Ishiwata S, Kato K, Nishikawa H, Takatsu F, Kato H, Kutsumi Y, Yamada N, Noma A, Yamaguchi H, and the Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) group. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Am J Cardiol 1994;73:1037-40.
17. Brunner R, Widder RA, Walter P, Borberg H, Oette K. Change in hemorrheological and biochemical parameters following membrane differential filtration. Int J Artif Organs 1995;18:794-8.
18. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL Apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans Circulation 1997;95:76-82.
19. McNamara DJ, Ahrens EF Jr, Kolb R, Brown CD, Parker TS, Davidson NO, Samuel P, McVie RM. Treatment of familial hypercholesterolemia by portacaval anastomosis: Effect on cholesterol metabolism and pool size. Proc Natl Acad Sci USA 1983;80:564-8.
20. Bilheimer DW, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984;311:1658-64.
21. Grossman M, Rader DJ, Muller DWM, Kolansky DM, Kozarsky K, Clark BJ III, Stein EA, Lupien PJ, Brewer HB Jr, Raper SE, Wilson JM. A pilot study of ex-vivo gene therapy for homozygous familial hypercholesterolemia. Nature Med 1995;1:1148-54.